1. Home
  2. RLTY vs ABEO Comparison

RLTY vs ABEO Comparison

Compare RLTY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLTY
  • ABEO
  • Stock Information
  • Founded
  • RLTY 2022
  • ABEO N/A
  • Country
  • RLTY United States
  • ABEO United States
  • Employees
  • RLTY N/A
  • ABEO N/A
  • Industry
  • RLTY Investment Managers
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RLTY Finance
  • ABEO Health Care
  • Exchange
  • RLTY Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • RLTY 259.2M
  • ABEO 224.3M
  • IPO Year
  • RLTY N/A
  • ABEO 1980
  • Fundamental
  • Price
  • RLTY $15.46
  • ABEO $5.04
  • Analyst Decision
  • RLTY
  • ABEO Strong Buy
  • Analyst Count
  • RLTY 0
  • ABEO 5
  • Target Price
  • RLTY N/A
  • ABEO $17.00
  • AVG Volume (30 Days)
  • RLTY 86.7K
  • ABEO 299.4K
  • Earning Date
  • RLTY 01-01-0001
  • ABEO 03-17-2025
  • Dividend Yield
  • RLTY 9.35%
  • ABEO N/A
  • EPS Growth
  • RLTY N/A
  • ABEO N/A
  • EPS
  • RLTY N/A
  • ABEO N/A
  • Revenue
  • RLTY N/A
  • ABEO N/A
  • Revenue This Year
  • RLTY N/A
  • ABEO N/A
  • Revenue Next Year
  • RLTY N/A
  • ABEO $15,721.96
  • P/E Ratio
  • RLTY N/A
  • ABEO N/A
  • Revenue Growth
  • RLTY N/A
  • ABEO 147.52
  • 52 Week Low
  • RLTY $11.38
  • ABEO $3.05
  • 52 Week High
  • RLTY $14.60
  • ABEO $8.87
  • Technical
  • Relative Strength Index (RSI)
  • RLTY 43.69
  • ABEO 36.63
  • Support Level
  • RLTY $15.73
  • ABEO $5.02
  • Resistance Level
  • RLTY $16.25
  • ABEO $5.45
  • Average True Range (ATR)
  • RLTY 0.30
  • ABEO 0.28
  • MACD
  • RLTY -0.04
  • ABEO -0.05
  • Stochastic Oscillator
  • RLTY 15.05
  • ABEO 12.62

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Share on Social Networks: